Novavax, Inc.
CH ˙ SWX ˙ US6700024010
SecurityCH:NVAX / Novavax, Inc.
InstitutionJpmorgan Chase & Co
Latest Disclosed Ownership75,200 shares
Latest Disclosed Value $ 608,368
Jpmorgan Chase & Co ownership in NVAX / Novavax, Inc.

On May 13, 2026 - Jpmorgan Chase & Co filed a 13F-HR/A form disclosing ownership of 75,200 shares of Novavax, Inc. (CH:NVAX) valued at $608,368 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 72,205 shares of Novavax, Inc.. This represents a change in shares of 4.15% during the quarter.

Jpmorgan Chase & Co has a history of taking positions in derivatives of the underlying security (NVAX) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

CH:NVAX / Novavax, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F/A-1 NOVAVAX COMMON 670002401 75,200 2,995 4.15 608 25.36 0.0000
2026-02-11 2025-12-31 13F NOVAVAX COMMON 670002401 72,205 -813 -1.11 485 -23.38 0.0000
2025-11-26 2025-09-30 13F/A-1 NOVAVAX COMMON 670002401 73,018 -11,253 -13.35 633 19.43 0.0000
2025-11-07 2025-09-30 13F NOVAVAX COMMON 670002401 73,018 -11,253 633 0.0000
2025-08-12 2025-06-30 13F NOVAVAX COMMON 670002401 84,271 2,282 2.78 531 0.95 0.0000
2025-05-12 2025-03-31 13F NOVAVAX COMMON 670002401 81,989 5,413 7.07 526 -14.63 0.0000
2025-02-12 2024-12-31 13F NOVAVAX COMMON 670002401 76,576 -3,299 -4.13 616 -38.99 0.0000
2024-12-26 2024-09-30 13F/A-1 NOVAVAX COMMON 670002401 79,875 -4,040 -4.81 1,009 -5.08 0.0001
2024-11-08 2024-09-30 13F NOVAVAX COMMON 670002401 79,875 -4,040 1,009 0.0001
2024-12-26 2024-06-30 13F/A-1 NOVAVAX COMMON 670002401 83,915 -34,376 -29.06 1,062 87.96 0.0001
2024-08-12 2024-06-30 13F NOVAVAX COMMON 670002401 83,915 -34,376 1,062 0.0001
2024-12-26 2024-03-31 13F/A-1 NOVAVAX COMMON 670002401 118,291 -41,923 -26.17 565 -26.53 0.0000
2024-05-10 2024-03-31 13F NOVAVAX COMMON 670002401 118,291 -41,923 565 0.0000
2024-12-26 2023-12-31 13F/A-1 NOVAVAX COMMON 670002401 160,214 25,687 19.09 769 -20.97 0.0001
2024-02-12 2023-12-31 13F NOVAVAX COMMON 670002401 160,214 25,687 769 0.0001
2023-11-14 2023-09-30 13F NOVAVAX COMMON 670002401 134,527 -3,132 -2.28 974 -4.79 0.0001
2023-08-11 2023-06-30 13F NOVAVAX COMMON 670002401 137,659 46,386 50.82 1,023 61.71 0.0001
2023-05-18 2023-03-31 13F/A-1 NOVAVAX COMMON 670002401 91,273 46,001 101.61 632 0.0001
2023-05-11 2023-03-31 13F NOVAVAX COMMON 670002401 43,221 -2,051 632 0.0001
2023-02-13 2022-12-31 13F NOVAVAX COMMON 670002401 45,272 -6,718 -12.92 0 -100.00 0.0001
2022-11-14 2022-09-30 13F NOVAVAX COMMON 670002401 51,990 -5,001 -8.78 946 -67.71 0.0001
2022-08-11 2022-06-30 13F NOVAVAX COMMON 670002401 56,991 -13,345 -18.97 2,930 -43.44 0.0004
2022-05-11 2022-03-31 13F NOVAVAX COMMON 670002401 70,336 10,277 17.11 5,180 -39.71 0.0006
2022-02-11 2021-12-31 13F/A-1 NOVAVAX COMMON 670002401 60,059 -199,329 -76.85 8,592 -84.02 0.0010
2022-02-10 2021-12-31 13F NOVAVAX COMMON 670002401 60,059 -199,329 8,592 0.0010
2021-11-12 2021-09-30 13F NOVAVAX COMMON 670002401 259,388 179,161 223.32 53,773 215.70 0.0066
2021-08-12 2021-06-30 13F NOVAVAX COMMON 670002401 80,227 -382,062 -82.65 17,033 -79.68 0.0020
2021-05-12 2021-03-31 13F NOVAVAX COMMON 670002401 462,289 232,064 100.80 83,817 226.49 0.0112
2021-02-19 2020-12-31 13F/A-1 NOVAVAX COMMON 670002401 230,225 87,198 60.97 25,672 66.27 0.0038
2021-02-11 2020-12-31 13F NOVAVAX COMMON 670002401 230,225 87,198 25,672 634.8869
2020-11-12 2020-09-30 13F/A-1 NOVAVAX COMMON 670002401 143,027 123,377 627.87 15,440 842.61 0.0026
2020-11-12 2020-09-30 13F NOVAVAX COMMON 670002401 143,027 15,440
2020-08-11 2020-06-30 13F NOVAVAX COMMON 670002401 19,650 -414,876 -95.48 1,638 -72.24 0.0003
2020-05-12 2020-03-31 13F NOVAVAX COMMON 670002401 434,526 160,205 58.40 5,900 440.79 0.0014
2020-02-11 2019-12-31 13F NOVAVAX COMMON 670002401 274,321 -7,727 -2.74 1,091 -22.90 0.0002
2019-11-12 2019-09-30 13F NOVAVAX COMMON 670002401 282,048 275,215 4,027.73 1,415 3,269.05 0.0003
2019-08-07 2019-06-30 13F NOVAVAX COMMON 670002401 6,833 -1,373,735 -99.51 42 -94.47 0.0000
2019-05-07 2019-03-31 13F NOVAVAX COMMON 670002104 1,380,568 -5,250,747 -79.18 760 -93.77 0.0002
2019-02-11 2018-12-31 13F NOVAVAX COMMON 670002104 6,631,315 394,857 6.33 12,201 4.06 0.0028
2018-11-13 2018-09-30 13F/A-1 NOVAVAX COMMON 670002104 6,236,458 1,674,958 36.72 11,725 91.84 0.0022
2018-11-07 2018-09-30 13F NOVAVAX COMMON 670002104 6,236,458 1,674,958 11,725
2018-08-14 2018-06-30 13F NOVAVAX COMMON 670002104 4,561,500 -2,519,512 -35.58 6,112 -58.90 0.0013
2018-05-10 2018-03-31 13F NOVAVAX COMMON 670002104 7,081,012 255,348 3.74 14,870 75.69 0.0032
2018-02-13 2017-12-31 13F NOVAVAX COMMON 670002104 6,825,664 627,323 10.12 8,464 18.74 0.0018
2017-11-09 2017-09-30 13F NOVAVAX COMMON 670002104 6,198,341 1,001,833 19.28 7,128 19.28 0.0016
2017-08-09 2017-06-30 13F NOVAVAX COMMON 670002104 5,196,508 1,488,403 40.14 5,976 25.92 0.0014
2017-05-10 2017-03-31 13F NOVAVAX COMMON 670002104 3,708,105 1,095,388 41.93 4,746 44.17 0.0011
2017-02-06 2016-12-31 13F NOVAVAX COMMON 670002104 2,612,717 -957,526 -26.82 3,292 -55.68 0.0008
2016-11-04 2016-09-30 13F NOVAVAX COMMON 670002104 3,570,243 1,873,773 110.45 7,427 -39.78 0.0018
2016-08-08 2016-06-30 13F NOVAVAX COMMON 670002104 1,696,470 380,232 28.89 12,334 81.60 0.0031
2016-05-10 2016-03-31 13F NOVAVAX COMMON 670002104 1,316,238 1,302,027 9,162.11 6,792 5,607.56 0.0017
2016-02-12 2015-12-31 13F NOVAVAX COMMON 670002104 14,211 542 3.97 119 23.96 0.0000
2015-11-13 2015-09-30 13F NOVAVAX COMMON 670002104 13,669 219 1.63 96 -36.00 0.0000
2015-08-14 2015-06-30 13F NOVAVAX COMMON 670002104 13,450 -12,582 -48.33 150 -30.56 0.0000
2015-05-15 2015-03-31 13F NOVAVAX COMMON 670002104 26,032 12,649 94.52 216 173.42 0.0000
2015-02-13 2014-12-31 13F NOVAVAX COMMON 670002104 13,383 -17,477 -56.63 79 -38.76 0.0000
2014-12-08 2014-09-30 13F/A-1 NOVAVAX COMMON 670002104 30,860 -11,086 -26.43 129 -40.00 0.0000
2014-11-14 2014-09-30 13F NOVAVAX COMMON 670002104 30,860 129
2014-02-26 2013-12-31 13F/A-1 NOVAVAX COMMON 670002104 41,946 12,291 41.45 215 128.72 0.0001
2014-02-13 2013-12-31 13F NOVAVAX COMMON 670002104 41,946 215
2013-10-31 2013-09-30 13F NOVAVAX COMMON 670002104 29,655 -4,772 -13.86 94 32.39 0.0000
2013-08-13 2013-06-30 13F NOVAVAX COMMON 670002104 34,427 34,427 71 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2019-08-07 2019-06-30 13F NOVAVAX OPTION Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-05-07 2019-03-31 13F NOVAVAX OPTION Call 710,000 391 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-13 2026-03-31 13F/A NOVAVAX OPTION Put 0 -100.00 0 -100.00 n/a n/a n/a
2026-05-13 2026-03-31 13F NOVAVAX OPTION Put 0 0 n/a n/a n/a
2026-02-11 2025-12-31 13F NOVAVAX OPTION Put 12,200 0.00 82 -22.86 n/a n/a n/a
2025-11-26 2025-09-30 13F/A NOVAVAX OPTION Put 12,200 -70.39 106 -59.46 n/a n/a n/a
2025-11-07 2025-09-30 13F NOVAVAX OPTION Put 12,200 106 n/a n/a n/a
2025-08-12 2025-06-30 13F NOVAVAX OPTION Put 41,200 0.00 260 -1.89 n/a n/a n/a
2025-05-12 2025-03-31 13F NOVAVAX OPTION Put 41,200 264 n/a n/a n/a
2025-02-12 2024-12-31 13F NOVAVAX OPTION Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-12-26 2024-09-30 13F/A NOVAVAX OPTION Put 21,000 -59.30 265 -59.42 n/a n/a n/a
2024-11-08 2024-09-30 13F NOVAVAX OPTION Put 21,000 265 n/a n/a n/a
2024-12-26 2024-06-30 13F/A NOVAVAX OPTION Put 51,600 653 n/a n/a n/a
2024-08-12 2024-06-30 13F NOVAVAX OPTION Put 51,600 653 n/a n/a n/a
2024-05-10 2024-03-31 13F NOVAVAX OPTION Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-12-26 2023-12-31 13F/A NOVAVAX OPTION Put 55,000 -78.43 264 -85.70 n/a n/a n/a
2024-02-12 2023-12-31 13F NOVAVAX OPTION Put 55,000 264 n/a n/a n/a
2023-11-14 2023-09-30 13F NOVAVAX OPTION Put 255,000 1,846 n/a n/a n/a
2023-08-11 2023-06-30 13F NOVAVAX OPTION Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-05-18 2023-03-31 13F/A NOVAVAX OPTION Put 1,130,000 54.60 7,831 111,771.43 n/a n/a n/a
2023-05-11 2023-03-31 13F NOVAVAX OPTION Put 1,130,000 7,831 n/a n/a n/a
2023-02-13 2022-12-31 13F NOVAVAX OPTION Put 730,900 -37.14 8 -99.97 n/a n/a n/a
2022-11-14 2022-09-30 13F NOVAVAX OPTION Put 1,162,700 108.59 21,161 -26.18 n/a n/a n/a
2022-08-11 2022-06-30 13F NOVAVAX OPTION Put 557,400 -30.95 28,667 -51.78 n/a n/a n/a
2022-05-11 2022-03-31 13F NOVAVAX OPTION Put 807,200 16.53 59,450 -40.01 n/a n/a n/a
2022-02-11 2021-12-31 13F/A NOVAVAX OPTION Put 692,700 99,105 n/a n/a n/a
2022-02-10 2021-12-31 13F NOVAVAX OPTION Put 692,700 99,105 n/a n/a n/a
2019-08-07 2019-06-30 13F NOVAVAX OPTION Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-05-07 2019-03-31 13F NOVAVAX OPTION Put 505,000 278 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.